Drug · DIN 02230446
MIREZE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 14, 2000; first marketed August 6, 1997.
- Drug Identification Number (DIN)
- 02230446
- Company (DIN owner)
- Allergan IncMarkham, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Liquid
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Nedocromil S01GX04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NEDOCROMIL SODIUM | 2 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 30, 1997: NOC 3973New Drug Submission (NDS)